Seventy-two percent who support track and trace, and 70% of those who have experienced a medicine or health product shortage, back an extension of the DSCSA’s final implementation date.
Sen. Crapo is leading a press conference in Twin Falls, ID, on addressing PBM practices that have grown increasingly complex and opaque in recent years at the expense of patients and taxpayers.
The 2023 National Association of Chain Drug Stores (NACDS) Total Store Expo kicks off August 12 in San Diego, CA.
NACDS is applauding today the introduction of bipartisan legislation in the U.S. Senate (S. 2477 - the Equitable Community Access to Pharmacist Services Act) that would help maintain the post-pandemic pharmacy access that Americans rely on and expect.
NACDS looks forward to continuing work with leaders in the U.S. Congress to address the “pharmaceutical benefit manipulation” that harms the most vulnerable in the Medicaid and Medicare programs.
More Than 190 Organizations Support S. 2447 to Provide Payment for Pharmacist Services for COVID-19, Flu, Strep, and RSV Under Medicare Part B.
A newly released NACDS video urges this message ahead of a July 26 legislative markup scheduled by the U.S. Senate Committee on Finance.
Anderson: “The vibrance and culture of the staff team align with NACDS’ mission and Roxanne is committed to sustaining and advancing NACDS’ extremely strong reputation”.
The FTC on Thursday voted, 3-0, “to issue a statement cautioning against reliance on prior advocacy statements and studies related to pharmacy benefit managers (PBM) that no longer reflect current market realities.”
Through the engagement of the membership, NACDS brought its pro-patient and pro-pharmacy perspective to the IRA during its Congressional consideration and continues to shape the IRA during its implementation.
